Clinical Trial: Clinical study on the first-line treatment of advanced non-small cell lung cancer with adebrelimab combined with platinum-based chemotherapy and vunakizumab (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study on the first-line treatment of advanced non-small cell lung cancer with adebrelimab combined with platinum-based chemotherapy and vunakizumab'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135185

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: NanJing First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333556

Published by HT Digital Content Services with permission from Health Daily Digest....